These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5481239)

  • 21. Treatment failures with L-dopa in Parkinsonism.
    Julsrud OJ
    Acta Neurol Scand Suppl; 1972; 51():123-4. PubMed ID: 4514337
    [No Abstract]   [Full Text] [Related]  

  • 22. [Habituation of trigemino-facial reflexes in parkinsonism treated with L-DOPA].
    Messina C
    Riv Neurol; 1970; 40(5):327-36. PubMed ID: 5507461
    [No Abstract]   [Full Text] [Related]  

  • 23. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F; Grünberger J; Schubert H
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of parkinsonism with the drug L-DOPA].
    Stoliarova LG; Kistenev BA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
    [No Abstract]   [Full Text] [Related]  

  • 25. Parkinsonism and dopa.
    N Z Med J; 1969 May; 69(444):306-7. PubMed ID: 5256210
    [No Abstract]   [Full Text] [Related]  

  • 26. A double blind study of 1-dopa treatment in Parkinson's disease.
    Rinne UK; Sonninen V
    Eur Neurol; 1968; 1(3):180-91. PubMed ID: 4880674
    [No Abstract]   [Full Text] [Related]  

  • 27. [Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results].
    Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1969 Oct; 90(5):329-49. PubMed ID: 5406104
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
    Rosati G; Agnetti V; Mura F; Granieri E
    Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term treatment of Parkinsonism with L-dopa].
    Presthus J; Holmsen R
    Tidsskr Nor Laegeforen; 1972 Nov; 92(33):2262-6. PubMed ID: 4630916
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long term treatment of a parkinsonism with l-dopa].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111-3. PubMed ID: 4590069
    [No Abstract]   [Full Text] [Related]  

  • 31. [The treatment of Parkinson's syndrome with L-dopa].
    Völler GW; Kerstan J
    Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
    [No Abstract]   [Full Text] [Related]  

  • 32. [Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study].
    Wälzholz U; Schönfelder H
    Nervenarzt; 1972 Oct; 43(10):531-2. PubMed ID: 4628192
    [No Abstract]   [Full Text] [Related]  

  • 33. [L-dopa treatment of parkinsonism].
    Szulc-Kuberska J; Niewodniczy A; Poźniak-Patewicz E; Wolczyk-Orzechowska M
    Neurol Neurochir Pol; 1973; 7(1):63-8. PubMed ID: 4511385
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment with L-dopa in Parkinsonian syndromes].
    De Renzi E; Pieczuro A
    Sist Nerv; 1970; 22(1):1-11. PubMed ID: 5502951
    [No Abstract]   [Full Text] [Related]  

  • 35. [The Rorschach test in parkinsonian patients. Its course during treatment with L dopa. Its prognostic value].
    Sevilla M; Vernet JP; Becle J; Darcourt G
    Ann Med Psychol (Paris); 1973 May; 1(5):577-608. PubMed ID: 4761931
    [No Abstract]   [Full Text] [Related]  

  • 36. Abnormal mouth-movements and oral damage associated with L-DOPA treatment.
    Sacks OW; Ross SJ; DePaola DP; Kohl MS
    Ann Dent; 1970; 29(4):130-44. PubMed ID: 5275661
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of Parkinson's disease with L-dopa: a current appraisal.
    Kofman O
    Can Med Assoc J; 1971 Mar; 104(6):483-7. PubMed ID: 5549988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of parkinsonian syndromes with L-dopa. Results and prospects].
    Fazio C
    Sist Nerv; 1970; 22(2):61-6. PubMed ID: 5504558
    [No Abstract]   [Full Text] [Related]  

  • 39. The treatment of parkinsonism. Current concepts.
    Yahr MD
    Med Clin North Am; 1972 Nov; 56(6):1377-92. PubMed ID: 4117524
    [No Abstract]   [Full Text] [Related]  

  • 40. Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy.
    Lipman IJ; Papadopoulos NM
    Dis Nerv Syst; 1973 Jan; 34(1):59-62. PubMed ID: 4709194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.